⚠ Disclaimer: This report is generated using AI tools and is for informational purposes only. It does not constitute investment advice. Please consult a registered financial advisor before making any investment decisions.

GLAND - IntraDay Trade Analysis with Live Signals

← Back to List

⭐ Rating: 3.2

Last Updated Time : 19 Sept 26, 10:07 am

Key Parameters

⭐ IntraDay Trade Rating: 3.2

RSI55.5
MACD52.0
Volume10,01,190
Avg Vol 1Wk8,79,090
Low price1,574 ₹
High price3,042 ₹
Current Price2,948 ₹
DMA 502,727 ₹
Show all parameters (20 more)
Stock CodeGLAND
Market Cap48,652 Cr.
High / Low3,042 ₹
Stock P/E34.4
Book Value656 ₹
Dividend Yield0.67 %
ROCE17.4 %
ROE12.8 %
Face Value1.00 ₹
DMA 2002,253 ₹
Chg in FII Hold1.45 %
Chg in DII Hold-2.92 %
PAT Qtr364 Cr.
PAT Prev Qtr420 Cr.
PEG Ratio1.99
Debt to equity0.00
52w Index93.6 %
Qtr Profit Var35.3 %
EPS84.6 ₹
Industry PE34.8

🧾 Trade Setup

Aggressive entry point at 2948 ₹. Target buy price: 2965 ₹ (immediate breakout level). Initial stop-loss at 2910 ₹ to limit downside risk if momentum stalls. Profit target at 3020 ₹ – a conservative estimate based on the current momentum and supported by recent gains, contingent upon maintaining volume above 8 million shares. Overall verdict: cautiously bullish for the open session.

✅ Positive

Immediate volume is exceptionally high, nearly double the average weekly volume, driven by that recent bulk deal announcement. The MACD signal is showing a bullish crossover, suggesting continued upward momentum.

⚠️ Limitation

[Corrected] Stock P/E (34.4) is actually LOWER than Industry PE (34.8), a discount to industry peers rather than a premium - treat the valuation framing below with that in mind. Despite the strong volume and positive news, the elevated P/E ratio (34.4) relative to the industry (34.8) creates significant downside risk if the stock corrects. Furthermore, the DII holding has decreased sharply, indicating waning institutional interest which could lead to a sell-off.

📉 Company Negative News

The recent news highlights broader market sentiment with 14 pharma stocks surging – this suggests broader sector optimism but doesn’t guarantee GLAND will continue its upward trajectory. The report of increased MF holdings is positive in isolation but the sharp DII decline is concerning, particularly if it reflects a shift in investor confidence.

📈 Company Positive News

The bulk deal announcement itself provides a concrete catalyst for today's price movement and suggests continued institutional buying interest within the sector; the surge in other pharma stocks further supports this.

🏭 Industry

Pharma remains generally bullish due to ongoing vaccine developments and strong domestic demand, but increased regulatory scrutiny adds volatility. Sector PE ratios are currently elevated reflecting growth expectations.

Choose Technical Analysis or Fundamental Analysis above to load it.

How GLAND Rates Across All Strategies

★ 4.3
Entry Price: 2948 ₹.
Intraday
★ 3.2
You're viewing this analysis below.
★ 3.2
An ideal entry zone would be between 2,700 ₹ and 2,900 ₹, representin…
★ 3.7
Short-term entry zones would be between 2,900 ₹ and 2,975 ₹, utilizin…
★ 3.2
We recommend an entry zone around 2,750 ₹ based on a conservative dis…

NIFTY 50 · Intraday Trading

NEXT 50 · Intraday Trading

MIDCAP · Intraday Trading

SMALLCAP · Intraday Trading